Global pharmaceuticals
SEC RESEARCH
ESTABLISHED COMPANY RESEARCH
LLYEli Lilly
LLY · Health care · SEC CIK 0000059478
Obesity-drug demand, manufacturing capacity, pipeline, and pricing
Concentration, competition, and clinical or policy setbacks
OFFICIAL FILINGS
Start with what the company filed.
EDGAR is the SEC’s public filing system. Confirm dates and amendments on the company page.
REPEATABLE PROCESS
Complete the homework before forming a conclusion.
Write the answer in your own words and update it after each filing or earnings call.
- Know the business□
Explain in plain language how the company makes money, who pays it, and what could make customers leave.
- Read the latest 10-K and 10-Q□
Compare revenue, margins, cash flow, debt, share count, segment results, and the risk-factor changes.
- Read material 8-K filings□
Look for acquisitions, financing, leadership changes, guidance updates, legal matters, and other material events.
- Review the earnings release□
Separate one-time items from the underlying trend and compare management guidance with the prior quarter.
- Listen to the conference call□
Take notes on management’s outlook and the analyst questions. Watch for changed wording, not just headline numbers.
- Check the balance sheet□
Measure cash, debt, interest cost, dilution risk, and whether the company can fund its plans without favorable markets.
- Compare competitors and valuation□
Use the same operating and valuation measures across peers; a good story can still be priced too aggressively.
- Write the thesis and disconfirmers□
Record what must go right, what would prove the thesis wrong, and which filing or metric will answer the question.
Eli Lilly is included as a company to research within health care, not as a recommendation. The list mixes established leaders with smaller, newer, or higher-volatility businesses so you can compare durability with potential growth—and with the extra risk that growth stories often carry.